HD-OPM Archive
Topics › Statins

Analysis of 125 million statin users links statins to lower Alzheimer's risk and mortality

Louis Nervegna · Apr 01, 2026 · ♥ 9 reactions · 0 comments · original Facebook post
StatinsBrain health & dementia
AI summary & key facts

A shared summary of a large observational analysis finding statin therapy associated with reduced Alzheimer's dementia risk and lower all-cause mortality, slightly stronger for hydrophilic statins such as rosuvastatin. It controlled for demographics, comorbidities and labs but is observational.

#statinsHD #statinsdementiaHD #dementiaHD #alzheimersHD

Research cited

BRAND NEW HUGE ANALYSIS OF ALZHEIMERS RISK ON 125 MILLION PEOPLE TAKING STATINS

CONCLUSION: "Our findings provide evidence that statin therapy is associated with REDUCED RISK of AD (Alzheimer's dementia) and related outcomes, extending prior observational data with broader population representation and rigorous confounder control. Pending further evidence, statins may be considered as part of comprehensive strategies to REDUCE AD risk."

Also of note

-The authors received no financial support for the research, authorship, and/or publication of this article.
-This is an observational analysis which has obvious limitations but many confounders here are better controlled for than in prior studies. In higher quality RCT studies we see a neutral effect, but the limitation in those studies is duration, ie the studies may just not go long enough to see this risk reduction.

Paper · J Alzheimers Dis · 2026Alzheimer's disease in patients prescribed statins: A real-world data analysis of U.S. patient health records.BackgroundEvidence from observational studies and randomized controlled trials (RCTs) remains discordant on the impact of statin therapy on long-term outcomes related to Alzheimer's disease. Observational studies find relatively large effect sizes; RCTs fail to demonstrate cognitive benefits. Methodological limitations in both approaches may explain the disconnect.ObjectiveTo bridge the gap between observational and…pubmed.ncbi.nlm.nih.govNo photo description available.No photo description available.
← newer: National Lipid Association consensus clarifies when to test older: Olezarsen cut triglycerides 64% but did not change plaque in →